Novartis Pharmaceuticals Corporation
Drug manufacturer · manufacturer
Unclaimed listing
171
Drug products
8
Therapeutic areas
About
Novartis Pharmaceuticals Corporation is listed in the FDA National Drug Code Directory with 171 marketed products, of which 169 are prescription drugs. Dosage forms include INJECTION, CAPSULE, TABLET, SOLUTION, SUSPENSION. Portfolio includes DEA-scheduled controlled substances.
What Novartis Pharmaceuticals Corporation makes
171 productsOther · 91Cardiovascular · 22Immunology & Inflammation · 21CNS & Psychiatry · 15Injectable & Infusion · 14Biologics & Vaccines · 3Anti-infective · 3Ophthalmic · 2
tablet · 88capsule · 30injection · 23kit · 8granule · 4ointment · 3patch · 3powder · 3suspension/ drops · 2solution/ drops · 2
- KISQALI FEMARA CO-PACKletrozole and ribociclib
- Xiidralifitegrast
- Myforticmycophenolic acid
- Myforticmycophenolic acid
- Arranonnelarabine
- ILEVROnepafenac
- Tasignanilotinib
- Tasignanilotinib
- Tasignanilotinib
- Sandostatinoctreotide acetate
- Sandostatin LAR Depotoctreotide acetate
- Sandostatinoctreotide acetate
- Sandostatin LAR Depotoctreotide acetate
- Sandostatin LAR Depotoctreotide acetate
- Sandostatinoctreotide acetate
Get a price
This listing is unclaimed, so post your requirement and every verified pharmacy licensed in your state will bid.
Request a quoteContact
Email and website are not published in the public registries — they are added when the listing is claimed.
From the FDA NDC Directory, refreshed 2026-08-15.
Is this your business?
Claim the listing to publish your catalog, answer buyer enquiries and bid on sourcing requests.
Claim this listing